Inhibition of PI3K/AKT/mTORC1 and PI3K/mTORC2/PKC/AKT pathways in GCB-DLBCL and BCR-subtype of ABC-DLBCL. This evidence concerns the gene PRRT2 and diffuse large B-cell lymphoma.